CONNECT 4'S MISSION IS TO HELP ALL HEALTHCARE STAKEHOLDERS NAVIGATE THE CHALLENGES OF REIMBURSEMENT AND MARKET ACCESS
In today’s environment, it is not enough to leave market access to manufacturers alone. Market access is patient access and it must be addressed collectively, with patients, providers, and manufacturers together. At Connect 4 Strategies, we have decades of health policy expertise in reimbursement consulting across life science and device companies as well as patient and provider groups. We believe that, with an increasing number of innovative drugs coming to market, reimbursement and market access are key problems for drug developers, patients, payers, and providers. We succeed when we aim to solve those problems together.
We are your solution for specific, tangible, quality work to address each stakeholder’s specific challenges. In other words, we do no cookie cutter work that can be resold to multiple clients. With Connect4Strategies, clients get:
Demonstrated and repeated success in (i) designing business solutions, (ii) driving significant strategic change, and (iii) creating opportunities to connect healthcare stakeholders. We provide detailed assessments of existing codes, descriptors and payment amounts, and how they differ in resources and work from what products in development are likely to need. We provide deep dive research into state Medicaid programs, their coverage criteria in specific classes, eligibility programs and implications for commercialization.
Proven track record of partnering with healthcare companies to navigate the challenges of reimbursement and market access. We specialize in working with life science companies, patient groups, and medical societies. We provide strategic consulting, project management, coalition building, convening stakeholders, stakeholder relationships in patient and provider communities, and leadership services.
Creative thoughtful solutions that come from 25 years of experience, a deep dive analysis of rules, regulations, statutes, and precedent, and the insight to create simple solutions for complex problems.
Connecting All Healthcare Stakeholders
Experience. Analysis. Insight.
Areas of Expertise
PATIENT/PROVIDER GROUPS
Staffing Haystack Project – a coalition of ultra-rare patient organizations
Craft Creative Solutions for patient organizations representing conditions like Pancreatic and other rare cancers, Alzheimer’s, Osteoporosis, Sickle Cell Disease and more…
Engage regional MACs and their medical directors for stem cell transplant providers
Extend Coalition Advocacy to HHS, CMS, CDC, SAMHSA, FDA, and more
Lead Meaningful Disease Awareness Efforts that lead to tangible results
Create Pricing and Access Strategies and Tutorials for manufacturers and patients
Develop training modules on Value, Clinical Endpoints, and more
Interview patients to create patient journey tools and insights
Interview providers to assess which providers drive treatment decisions
Simplify complex policy concepts and provide policy guidance & solutions
Support ASCO Planning and Engagement
Develop and Implement Policy Forums
Assess and Engage with Clinical Pathways and Decision Tools
Pricing versus Reimbursement – Engagement Strategies
Develop Payer Engagement Surveys
Create Substantive Stakeholder Collaborations
LIFE SCIENCE COMPANIES
Rare and Ultra Rare Reimbursement Landscaping, Gap Analysis, and Solution Oriented Strategies Before Launch
Forensic analysis of market access opportunities across portfolio of marketed, pipeline and BD products
HHS/CMS Engagement Strategies
Deep Dive Analysis and Strategic Coding Solutions from CPT, ICD, HCPC, and other critical codes
Medicare, Commercial and Medicaid Reimbursement Strategies
New Technology Add-On Payment Analysis
Payer lens on FDA Interactions
Disease Specific Executive/Legislative Strategic Policy Implementation
Opioids - Aligning Government Initiatives from Pain to Addiction
Due Diligence for New M&A opportunities
Drug, Biologics, Device, and Diagnostic Experience
Patient Advocacy
Patient Journey Mapping/Assessment of Key Providers and Treatment Decision Makers
FDA Priority Review Vouchers
MEDICAL DEVICE COMPANIES
Payer Mix Analysis
Medical and Health Outcome Projects
Commercial Payer Strategies
CMS coding and payment perspectives and strategies
Payer Advisory Boards
Patient Perspectives’ Integration at FDA
Registries in Place of REMS
Medicaid FFS and MCO Perspectives
CMS Benefit Categories
Benefit-Risk Analysis
“The art of war teaches us to rely not on the likelihood of the enemy’s not coming, but on our own readiness to receive him; not on the chance of his not attacking, but rather on the fact that we have made our position unassailable.”